Diabetes UK replies to Dr Aseem MalhotraBMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f3999 (Published 25 June 2013) Cite this as: BMJ 2013;346:f3999
- Barbara Young, chief executive1
- 1Diabetes UK, Macleod House, London NW1 7AA, UK
In his Observations article in the issue of 25 May Dr Aseem Malhotra implied that Diabetes UK’s view on the link between sugar and type 2 diabetes has been influenced by a corporate partnership.1
While we defend his right to criticise our view, we were disappointed that he called our integrity into question because he disagrees with us, without providing any evidence to support his implication. He hadn’t raised this with us directly first and allowed us to demonstrate our absolute commitment to an evidence based approach.
We would never allow our view of the science to be swayed by a corporate partnership. We have a long history as an evidence based organisation giving independent advice, and we are committed …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial